BU
EXAS

BBVA USA’s Exact Sciences EXAS Stock Holding History

BBVA USA’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$165K Sell
1,731
-1,034
-37% -$109K 0.01% 465
2021
Q2 		$344K Buy
+2,765
New +$330K 0.02% 394

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBVA USA's EXAS Position: Q3 2021 in Review

BBVA USA reduced its Exact Sciences (EXAS) stake by 37% in Q3 2021, selling an estimated $109K and leaving 1,731 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #465.

BBVA USA first reported a position in EXAS in Q2 2021 and has held it in 2 quarters since. The position peaked at $344K in Q2 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • BBVA USA held 1,731 shares of Exact Sciences worth $165K as of Q3 2021.
  • BBVA USA sold 1,034 Exact Sciences shares in Q3 2021, an estimated $109K.
  • Exact Sciences made up 0.01% of BBVA USA's portfolio in Q3 2021, its #465 holding.
  • BBVA USA first reported a position in Exact Sciences in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Exact Sciences position peaked at $344K in Q2 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.